These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31128349)

  • 1. Prenatal perfluorooctanoic acid exposure is associated with early onset atopic dermatitis in 5-year-old children.
    Wen HJ; Wang SL; Chuang YC; Chen PC; Guo YL
    Chemosphere; 2019 Sep; 231():25-31. PubMed ID: 31128349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal perfluorooctanoic acid exposure and glutathione s-transferase T1/M1 genotypes and their association with atopic dermatitis at 2 years of age.
    Wen HJ; Wang SL; Chen PC; Guo YL
    PLoS One; 2019; 14(1):e0210708. PubMed ID: 30650146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy.
    Wang IJ; Hsieh WS; Chen CY; Fletcher T; Lien GW; Chiang HL; Chiang CF; Wu TN; Chen PC
    Environ Res; 2011 Aug; 111(6):785-91. PubMed ID: 21601844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
    Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
    Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
    Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.
    Forns J; Verner MA; Iszatt N; Nowack N; Bach CC; Vrijheid M; Costa O; Andiarena A; Sovcikova E; Høyer BB; Wittsiepe J; Lopez-Espinosa MJ; Ibarluzea J; Hertz-Picciotto I; Toft G; Stigum H; Guxens M; Liew Z; Eggesbø M
    Environ Health Perspect; 2020 May; 128(5):57002. PubMed ID: 32378965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort.
    Dalsager L; Christensen N; Husby S; Kyhl H; Nielsen F; Høst A; Grandjean P; Jensen TK
    Environ Int; 2016 Nov; 96():58-64. PubMed ID: 27608427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function development.
    Kung YP; Lin CC; Chen MH; Tsai MS; Hsieh WS; Chen PC
    Environ Res; 2021 Jan; 192():110178. PubMed ID: 32991923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometry in 5- to 9-Year-Old Greenlandic and Ukrainian Children in Relation to Prenatal Exposure to Perfluorinated Alkyl Substances.
    Høyer BB; Ramlau-Hansen CH; Vrijheid M; Valvi D; Pedersen HS; Zviezdai V; Jönsson BA; Lindh CH; Bonde JP; Toft G
    Environ Health Perspect; 2015 Aug; 123(8):841-6. PubMed ID: 25809098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorinated compound levels in cord blood and neurodevelopment at 2 years of age.
    Chen MH; Ha EH; Liao HF; Jeng SF; Su YN; Wen TW; Lien GW; Chen CY; Hsieh WS; Chen PC
    Epidemiology; 2013 Nov; 24(6):800-8. PubMed ID: 24036611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
    Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
    Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study.
    Kobayashi S; Azumi K; Goudarzi H; Araki A; Miyashita C; Kobayashi S; Itoh S; Sasaki S; Ishizuka M; Nakazawa H; Ikeno T; Kishi R
    J Expo Sci Environ Epidemiol; 2017 May; 27(3):251-259. PubMed ID: 27553991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Exposure to Perfluoroalkyl Substances With Thyroid Hormone Concentrations and Birth Size.
    Xiao C; Grandjean P; Valvi D; Nielsen F; Jensen TK; Weihe P; Oulhote Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):735-45. PubMed ID: 31665456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.